Skip to main content
. 2020 May 25;26(3):318–327. doi: 10.3350/cmh.2019.0019n

Figure 1.

Figure 1.

Indications for percutaneous liver biopsies during the overall study period (2001 to 2018). Chronic hepatitis B was the most common indication for liver biopsy, followed by malignancy, non-alcoholic fatty liver disease, drug-induced liver disease, and alcohol-related liver disease (8.2%). LC, liver cirrhosis; HBV, hepatitis B virus; NAFLD, non-alcoholic fatty liver disease; PBC, primary biliary cholangitis; HCV, hepatitis C virus.